TxCell
Develops cell-based immuno-therapies for the treatment of severe chronic inflammatory diseases
TxCell has raised €11M across 1 funding round from 2 investors, most recently a Growth/Late round in Feb 2017. Based in France; founded 2001; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€11M
€11,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2017-02
latest 2017-02
Funding by year
EUR raised per yearTxCell — funding by year — interactive chart.
Data table
| TxCell — funding by year | |
|---|---|
| 2017 | €11M |
Signals
High confidenceRaise-next likelihood7
base rate 37% for Growth/Late
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-02-01 | Growth/Late | €11M | Auriga Partners,Bpifrance | View deal → |
Investors
2Related news
Similar companies
same sector or country- Mistral AI€6.5BFrance · AI
- Automotive Cells Company (ACC)€4.4BFrance · Transportation
- Philips€2.6BNetherlands · Healthtech
- Verkor€2.4BFrance · Energy
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData